Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs ALX Oncology Holdings
Over the past year BBOT returned −80.9% and ALXO returned −12.1%; their daily moves had a correlation of 0.14.
BBOT −80.9% ALXO −12.1%Growth of $1, one year, split-adjusted
| Metric | BBOT | ALXO |
|---|---|---|
| Price | $2.35 | $1.38 |
| Market cap | $188.4M | $190.8M |
| Today | +1.29% | +6.98% |
| 1 month | −32.9% | +24.3% |
| 6 months | −71.8% | −34.0% |
| Year to date | −81.2% | +22.1% |
| 1 year | −80.9% | −12.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.7M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 88.2% | 93.5% |
| Short % of float | 13.9% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).